Figure 44

![Figure 44: GFAP immunohistochemistry in cerebral cortex sections demonstrates that NC Curc treatment restores astrocyte activation levels induced by STZ toward baseline, indicating reduced neuroinflammatory gliosis in the treated Alzheimer disease model.]()

> Source: Anne Suély Pinto Savall et al. "Nanoencapsulated Curcumin: Enhanced Efficacy in Reversing Memory Loss in An Alzh." *Brain sciences*, 2024. PMID: [38391705](https://pubmed.ncbi.nlm.nih.gov/38391705/)

<figure>
  <img src="" alt="GFAP immunohistochemistry in cerebral cortex sections demonstrates that NC Curc treatment restores astrocyte activation levels induced by STZ toward baseline, indicating reduced neuroinflammatory gliosis in the treated Alzheimer disease model." />
  <figcaption>Figure 44. GFAP immunohistochemistry in cerebral cortex sections demonstrates that NC Curc treatment restores astrocyte activation levels induced by STZ toward baseline, indicating reduced neuroinflammatory gliosis in the treated Alzheimer disease model.<br>  Source: Anne Suély Pinto Savall et al. "Nanoencapsulated Curcumin: Enhanced Efficacy in Reversing Memory Loss in An Alzh." <em>Brain sciences</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38391705/">38391705</a></figcaption>
</figure>